A ménage à trois made in heaven: G-protein-coupled receptors, lipids and TRP channels

Cell Calcium

Volumn 50, Issue 1, 2011, Pages 9-26

  Kukkonen, Jyrki P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

2 Arachidonoylglycerol; 4 Hydroxy 2 nonenal; Anandamide; Arachidonic acid; Ceramide; Ceramide 1 phosphate; Cholesterol; Cyclooxygenase; Diacylglycerol; Diacylglycerol kinase; Diacylglycerol lipase; Eicosanoid; Endocannabinoid; Endovanilloid; Epoxygenase; Free fatty acid; G protein coupled receptor; Glycerophospholipid; Inositol 1,4,5 trisphosphate; Lipase; Lipid; Lipid kinase; Lipid signaling; Lipoxygenase; Lysophosphatidic acid; Lysophosphatidylcholine; Monoacylglycerol lipase; Mustard oil; Phosphatidic acid; Phosphatidic acid phosphohydrolase; Phosphatidylcholine; Phosphatidylethanolamine; Phosphatidylinositol; Phosphatidylserine; Phosphoinositide 3 kinase; Phospholipase; Phospholipid; Platelet activating factor; Prostaglandin; Sphingolipid; Sphingomyelin; Sphingosine; Sphingosine 1 phosphate; Sphingosylphosphorylcholine; TRP channel

Indexed keywords

DIACYLGLYCEROL; ENDOCANNABINOID; ENDOVANNILOID; FATTY ACID; G PROTEIN COUPLED RECEPTOR; LIGAND; LIPID; LIPIDOME; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE A1; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPASE D; POLYCYSTIN; PROTEIN IP3; PROTEIN TRPML; SPHINGOMYELIN; SPHINGOSINE; STEROID; THROMBOCYTE ACTIVATING FACTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; LIPID METABOLISM; LIPID PEROXIDATION; NITRATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 79960271750     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2011.04.005     Document Type: Review

References (236)

1. Barritt G.J. Receptor-activated Ca2+ inflow in animal cells: a variety of pathways tailored to meet different intracellular Ca2+ signalling requirements. Biochem. J. 1999, 337:153-169.
2. Harding A.S., Hancock J.F. Using plasma membrane nanoclusters to build better signaling circuits. Trends Cell Biol. 2008, 18:364-371.
3. Neves S.R., Ram P.T., Iyengar R. G protein pathways. Science 2002, 296:1636-1639.
4. Milligan G., Kostenis E., Heterotrimeric G-proteins: a short history. Br. J. Pharmacol. 2006, 147(Suppl 1):S46-55.
5. Kinnamon S.C. Umami taste transduction mechanisms. Am. J. Clin. Nutr. 2009, 90:753S-755S.
6. Smrcka A.V. G protein betagamma subunits: central mediators of G protein-coupled receptor signaling. Cell. Mol. Life Sci. 2008, 65:2191-2214.
7. Ritter S.L., Hall R.A. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat. Rev. Mol. Cell Biol. 2009, 10:819-830.
8. Rajagopal S., Rajagopal K., Lefkowitz R.J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 2010, 9:373-386.
9. Leslie C.C. Regulation of arachidonic acid availability for eicosanoid production. Biochem. Cell Biol. 2004, 82:1-17.
10. Buczynski M.W., Dumlao D.S., Dennis E.A. Thematic Review Series: proteomics. an integrated omics analysis of eicosanoid biology. J. Lipid Res. 2009, 50:1015-1038.
11. Shuttleworth T.J. Arachidonic acid, ARC channels, and Orai proteins. Cell Calcium 2009, 45:602-610.
12. Chow S.C, Jondal M. Polyunsaturated free fatty acids stimulate an increase in cytosolic Ca2+ by mobilizing the inositol 1,4,5-trisphosphate-sensitive Ca2+ pool in T cells through a mechanism independent of phosphoinositide turnover. J. Biol. Chem. 1990, 265:902-907.
13. Hardy S.J., Robinson B.S., Ferrante A., Hii C.S., Johnson D.W., Poulos A., Murray A.W. Polyenoic very-long-chain fatty acids mobilize intracellular calcium from a thapsigargin-insensitive pool in human neutrophils. The relationship between Ca2+ mobilization and superoxide production induced by long- and very-long-chain fatty acids. Biochem. J. 1995, 311(Pt 2):689-697.
14. Aoki J., Inoue A., Okudaira S. Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta 2008, 1781:513-518.
15. Tigyi G. Aiming drug discovery at lysophosphatidic acid targets. Br. J. Pharmacol. 2010, 161:241-270.
16. Murakami M., Taketomi Y., Miki Y., Sato H., Hirabayashi T., Yamamoto K. Recent progress in phospholipase A(2) research: from cells to animals to humans. Prog. Lipid Res. 2011, 50:152-192.
17. Yan W., Jenkins C.M., Han X., Mancuso D.J., Sims H.F., Yang K., Gross R.W. The highly selective production of 2-arachidonoyl lysophosphatidylcholine catalyzed by purified calcium-independent phospholipase A2gamma: identification of a novel enzymatic mediator for the generation of a key branch point intermediate in eicosanoid signaling. J. Biol. Chem. 2005, 280:26669-26679.
18. Ghosh M., Tucker D.E., Burchett S.A., Leslie C.C. Properties of the Group IV phospholipase A2 family. Prog. Lipid Res. 2006, 45:487-510.
19. Schaloske R.H., Dennis E.A. The phospholipase A2 superfamily and its group numbering system. Biochim. Biophys. Acta 2006, 1761:1246-1259.
20. Honda Z., Ishii S., Shimizu T. Platelet-activating factor receptor. J. Biochem. 2002, 131:773-779.
21. Ueda N., Yamanaka K., Yamamoto S. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J. Biol. Chem. 2001, 276:35552-35557.
22. Di Marzo V., Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr. Opin. Lipidol. 2007, 18:129-140.
23. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 2009, 89:309-380.
24. De Petrocellis L., Di Marzo V. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J. Neuroimmune. Pharmacol. 2010, 5:103-121.
25. Labar G., Wouters J., Lambert D.M. A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling. Curr. Med. Chem. 2010, 17:2588-2607.
26. J.R. Savinainen, S.M. Saario, J.T. Laitinen, The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors, Acta Physiol. (Oxf.), in press. doi:10.1111/j.1748-1716.2011.02280.x.
27. Antollini S.S., Barrantes F.J. Unique effects of different fatty acid species on the physical properties of the torpedo acetylcholine receptor membrane. J. Biol. Chem. 2002, 277:1249-1254.
28. Meves H. Arachidonic acid and ion channels: an update. Br. J. Pharmacol. 2008, 155:4-16.
29. Beech D.J., Bahnasi Y.M., Dedman A.M., Al-Shawaf E. TRPC channel lipid specificity and mechanisms of lipid regulation. Cell Calcium 2009, 45:583-588.
30. Raghu P., Hardie R.C. Regulation of Drosophila TRPC channels by lipid messengers. Cell Calcium 2009, 45:566-573.
31. Roberts-Crowley M.L., Mitra-Ganguli T., Liu L., Rittenhouse A.R. Regulation of voltage-gated Ca2+ channels by lipids. Cell Calcium 2009, 45:589-601.
32. Shirai Y., Kashiwagi K., Yagi K., Sakai N., Saito N. Distinct effects of fatty acids on translocation of gamma- and epsilon-subspecies of protein kinase C. J. Cell Biol. 1998, 143:511-521.
33. Kota B.P., Huang T.H., Roufogalis B.D. An overview on biological mechanisms of PPARs. Pharmacol. Res. 2005, 51:85-94.
34. Bordoni A., Di Nunzio M., Danesi F., Biagi P.L. Polyunsaturated fatty acids: from diet to binding to ppars and other nuclear receptors. Genes Nutr. 2006, 1:95-106.
35. Zeldin D.C. Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 2001, 276:36059-36062.
36. Kim C., Kim J.Y., Kim J.H. Cytosolic phospholipase A(2), lipoxygenase metabolites, and reactive oxygen species. BMB Rep. 2008, 41:555-559.
37. Ariel A, Serhan C.N. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007, 28:176-183.
38. Rouzer C.A., Marnett L.J. Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids. J. Biol. Chem. 2008, 283:8065-8069.
39. Yates M.L., Barker E.L. Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. Mol. Pharmacol. 2009, 76:11-17.
40. Anderson K.M., Ondrey F., Harris J.E. ETYA, a pleotropic membrane-active arachidonic acid analogue affects multiple signal transduction pathways in cultured transformed mammalian cells. Clin. Biochem. 1992, 25:1-9.
41. Seuwen K., Ludwig M.G., Wolf R.M. Receptors for protons or lipid messengers or both?. J. Recept. Signal Transduct. Res. 2006, 26:599-610.
42. Ross R.A. The enigmatic pharmacology of GPR55. Trends Pharmacol. Sci. 2009, 30:156-163.
43. Alexander S.P., Kendall D.A. The complications of promiscuity: endocannabinoid action and metabolism. Br. J. Pharmacol. 2007, 152:602-623.
44. Simon G.M., Cravatt B.F. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J. Biol. Chem. 2008, 283:9341-9349.
45. Okamoto Y., Tsuboi K., Ueda N. Enzymatic formation of anandamide. Vitam. Horm. 2009, 81:1-24.
46. De Petrocellis L., Di Marzo V. Role of endocannabinoids and endovanilloids in Ca2+ signalling. Cell Calcium 2009, 45:611-624.
47. Thabuis C., Tissot-Favre D., Bezelgues J.B., Martin J.C., Cruz-Hernandez C., Dionisi F., Destaillats F. Biological functions and metabolism of oleoylethanolamide. Lipids 2008, 43:887-894.
48. Petrosino S., Iuvone T., Di Marzo V. N-palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities. Biochimie 2010, 92:724-727.
49. Hwang S.W., Cho H., Kwak J., Lee S.Y., Kang C.J., Jung J., Cho S., Min K.H., Suh Y.G., Kim D., Oh U. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6155-6160.
50. Catala A. A synopsis of the process of lipid peroxidation since the discovery of the essential fatty acids. Biochem. Biophys. Res. Commun. 2010, 399:318-323.
51. Gueraud F., Atalay M., Bresgen N., Cipak A., Eckl P.M., Huc L., Jouanin I., Siems W., Uchida K. Chemistry and biochemistry of lipid peroxidation products. Free Radic. Res. 2010, 44:1098-1124.
52. Trevisani M., Siemens J., Materazzi S., Bautista D.M., Nassini R., Campi B., Imamachi N., Andre E., Patacchini R., Cottrell G.S., Gatti R., Basbaum A.I., Bunnett N.W., Julius D., Geppetti P. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13519-13524.
53. Freeman B.A., Baker P.R., Schopfer F.J., Woodcock S.R., Napolitano A., d'Ischia M. Nitro-fatty acid formation and signaling. J. Biol. Chem. 2008, 283:15515-15519.
54. Taylor-Clark T.E., Ghatta S., Bettner W., Undem B.J. Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1. Mol. Pharmacol. 2009, 75:820-829.
55. Alexander S.P., Mathie A., Peters J.A. Guide to Receptors and Channels (GRAC), 4th Ed. Br. J. Pharmacol 2009, 158(Suppl 1):S1-S254.
56. Rebecchi M.J., Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 2000, 80:1291-1335.
57. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 2001, 70:281-312.
58. Sukumaran S.K., McNamara G., Prasadarao N.V. Escherichia coli K-1 interaction with human brain micro-vascular endothelial cells triggers phospholipase C-gamma1 activation downstream of phosphatidylinositol 3-kinase. J. Biol. Chem. 2003, 278:45753-45762.
59. Cockcroft S. The latest phospholipase C, PLCeta, is implicated in neuronal function. Trends Biochem. Sci. 2005, 31:4-7.
60. Katan M. New insights into the families of PLC enzymes: looking back and going forward. Biochem. J. 2005, 391:e7-e9.
61. Oude Weernink P.A., Han L., Jakobs K.H., Schmidt M. Dynamic phospholipid signaling by G protein-coupled receptors. Biochim. Biophys. Acta 2007, 1768:888-900.
62. Stewart A.J., Morgan K., Farquharson C., Millar R.P. Phospholipase C-eta enzymes as putative protein kinase C and Ca2+ signalling components in neuronal and neuroendocrine tissues. Neuroendocrinology 2007, 86:243-248.
63. Kim Y.H., Park T.J., Lee Y.H., Baek K.J., Suh P.G., Ryu S.H., Kim K.T. Phospholipase C-delta1 is activated by capacitative calcium entry that follows phospholipase C-beta activation upon bradykinin stimulation. J. Biol. Chem. 1999, 274:26127-26134.
64. Murthy K.S., Zhou H., Huang J., Pentyala S.N. Activation of PLC-delta1 by Gi/o-coupled receptor agonists. Am. J. Physiol. Cell. Physiol. 2004, 287:C1679-C1687.
65. Guo Y., Rebecchi M., Scarlata S. Phospholipase Cbeta2 binds to and inhibits phospholipase Cdelta1. J. Biol. Chem. 2005, 280:1438-1447.
66. Johansson L., Ekholm M.E., Kukkonen J.P. Multiple phospholipase activation by OX(1) orexin/hypocretin receptors. Cell. Mol. Life. Sci. 2008, 65:1948-1956.
67. Willars G.B., Nahorski S.R., Challiss R.A. Differential regulation of muscarinic acetylcholine receptor-sensitive polyphosphoinositide pools and consequences for signaling in human neuroblastoma cells. J. Biol. Chem. 1998, 273:5037-5046.
68. Xu C., Watras J., Loew L.M. Kinetic analysis of receptor-activated phosphoinositide turnover. J. Cell Biol. 2003, 161:779-791.
69. Mitchell C.J., Kelly M.M., Blewitt M., Wilson J.R., Biden T.J. Phospholipase C-gamma mediates the hydrolysis of phosphatidylinositol, but not of phosphatidylinositol 4,5-bisphoshate, in carbamylcholine-stimulated islets of langerhans. J. Biol. Chem. 2001, 276:19072-19077.
70. Pattni K., Banting G. Ins(1,4,5)P3 metabolism and the family of IP3-3kinases. Cell. Signal. 2004, 16:643-654.
71. Xie W., Kaetzel M.A., Bruzik K.S., Dedman J.R., Shears S.B., Nelson D.J. Inositol 3,4,5,6-tetrakisphosphate inhibits the calmodulin-dependent protein kinase II-activated chloride conductance in T84 colonic epithelial cells. J. Biol. Chem. 1996, 271:14092-14097.
72. Kavran J.M., Klein D.E., Lee A., Falasca M., Isakoff S.J., Skolnik E.Y., Lemmon M.A. Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains. J. Biol. Chem. 1998, 273:30497-30508.
73. Tolias K.F., Cantley L.C. Pathways for phosphoinositide synthesis. Chem. Phys. Lipids 1999, 98:69-77.
74. Yang X., Rudolf M., Carew M.A., Yoshida M., Nerreter V., Riley A.M., Chung S.K., Bruzik K.S., Potter B.V., Schultz C., Shears S.B. Inositol 1,3,4-trisphosphate acts in vivo as a specific regulator of cellular signaling by inositol 3,4,5,6-tetrakisphosphate. J. Biol. Chem. 1999, 274:18973-18980.
75. Barker C.J., Illies C., Gaboardi G.C., Berggren P.O. Inositol pyrophosphates: structure, enzymology and function. Cell. Mol. Life. Sci. 2009, 66:3851-3871.
76. Cullen P.J., Lockyer P.J. Integration of calcium and Ras signalling. Nat. Rev. Mol. Cell Biol. 2002, 3:339-348.
77. Carrasco S., Merida I. Diacylglycerol, when simplicity becomes complex. Trends Biochem. Sci. 2007, 32:27-36.
78. Yang C., Kazanietz M.G., Chimaerins: GAPs that bridge diacylglycerol signalling and the small G-protein Rac. Biochem. J. 2007, 403:1-12.
79. Hofmann T., Obukhov A.G., Schaefer M., Harteneck C., Gudermann T., Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 1999, 397:259-263.
80. Okada T., Inoue R., Yamazaki K., Maeda A., Kurosaki T., Yamakuni T., Tanaka I., Shimizu S., Ikenaka K., Imoto K., Mori Y. Molecular and functional characterization of a novel mouse transient receptor potential protein homologue TRP7. Ca(2+)-permeable cation channel that is constitutively activated and enhanced by stimulation of G protein-coupled receptor. J. Biol. Chem. 1999, 274:27359-27370.
81. Lucas P., Ukhanov K., Leinders-Zufall T., Zufall F. A diacylglycerol-gated cation channel in vomeronasal neuron dendrites is impaired in TRPC2 mutant mice: mechanism of pheromone transduction. Neuron 2003, 40:551-561.
82. Venkatachalam K., Montell C. TRP channels. Annu. Rev. Biochem. 2007, 76:387-417.
83. Merida I., Avila-Flores A., Merino E. Diacylglycerol kinases: at the hub of cell signalling. Biochem. J. 2008, 409:1-18.
84. Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., Matias I., Schiano-Moriello A., Paul P., Williams E.J., Gangadharan U., Hobbs C., Di Marzo V., Doherty P. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 2003, 163:463-468.
85. Lee M.W., Severson D.L. Partial purification of a diacylglycerol lipase from bovine aorta. Biochem. J. 1994, 298(Pt 1):213-219.
86. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell. Dev. Biol. 2001, 17:615-675.
87. Wymann M.P., Zvelebil M., Laffargue M. Phosphoinositide 3-kinase signalling-which way to target?. Trends. Pharmacol. Sci. 2003, 24:366-376.
88. Rodriguez-Viciana P., Warne P.H., Dhand R., Vanhaesebroeck B., Gout I., Fry M.J., Waterfield M.D., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994, 370:527-532.
89. Kurig B., Shymanets A., Bohnacker T., Prajwal C., Brock M.R., Ahmadian M., Schaefer A., Gohla C., Harteneck M.P., Wymann E., Jeanclos B., Nurnberg Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20312-20317.
90. Ballou L.M., Chattopadhyay M., Li Y., Scarlata S., Lin R.Z. Galphaq binds to p110alpha/p85alpha phosphoinositide 3-kinase and displaces Ras. Biochem. J. 2006, 394:557-562.
91. Bousquet C., Guillermet-Guibert J., Saint-Laurent N., Archer-Lahlou E., Lopez F., Fanjul M., Ferrand A., Fourmy D., Pichereaux C., Monsarrat B., Pradayrol L., Esteve J.P., Susini C. Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway. EMBO J. 2006, 25:3943-3954.
92. Scott M.T., Ingram A., Ball K.L. PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J. 2002, 21:6771-6780.
93. Newton A.C. Lipid activation of protein kinases. J. Lipid Res. 2009, 50(Suppl.):S266-S271.
94. Pochynyuk O., Tong Q., Staruschenko A., Ma H.P., Stockand J.D. Regulation of the epithelial Na+ channel (ENaC) by phosphatidylinositides. Am. J. Physiol. Renal Physiol. 2006, 290:F949-F957.
95. Michailidis I.E., Zhang Y., Yang J. The lipid connection-regulation of voltage-gated Ca(2+) channels by phosphoinositides. Pflugers Arch. 2007, 455:147-155.
96. Falasca M., Maffucci T. Rethinking phosphatidylinositol 3-monophosphate. Biochim. Biophys. Acta 2009, 1793:1795-1803.
97. Poccia D., Larijani B. Phosphatidylinositol metabolism and membrane fusion. Biochem. J. 2009, 418:233-246.
98. Graham T.R., Burd C.G. Coordination of Golgi functions by phosphatidylinositol 4-kinases. Trends Cell Biol. 2011, 21:113-121.
99. Jiang H., Luo J.Q., Urano T., Frankel P., Lu Z., Foster D.A., Feig L.A. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 1995, 378:409-412.
100. Jenkins G.M., Frohman M.A. Phospholipase D: a lipid centric review. Cell. Mol. Life. Sci. 2005, 62:2305-2316.
101. Corrotte M., Nyguyen A.P., Harlay M.L., Vitale N., Bader M.F., Grant N.J. Ral isoforms are implicated in FcgammaR-mediated phagocytosis: activation of phospholipase D by RalA. J. Immunol. 2010, 185:2942-2950.
102. Exton J.H., Phospholipase D. Biochim. Biophys. Acta 1998, 1436:105-115.
103. Sung T.C., Zhang Y., Morris A.J., Frohman M.A. Structural analysis of human phospholipase D1. J. Biol. Chem. 1999, 274:3659-3666.
104. Zhang Y., Altshuller Y.M., Hammond S.M., Hayes F., Morris A.J., Frohman M.A. Loss of receptor regulation by a phospholipase D1 mutant unresponsive to protein kinase C. EMBO J. 1999, 18:6339-6348.
105. Newton A.C. Protein kinase C: poised to signal. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E395-E402.
106. Aittaleb M., Boguth C.A., Tesmer J.J. Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors. Mol. Pharmacol. 2010, 77:111-125.
107. Bodemann B.O., White M.A. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer 2008, 8:133-140.
108. Ferro E., Trabalzini L. RalGDS family members couple Ras to Ral signalling and that's not all. Cell. Signal. 2010, 22:1804-1810.
109. Godin C.M., Ferreira L.T., Dale L.B., Gros R., Cregan S.P., Ferguson S.S. The small GTPase Ral couples the angiotensin II type 1 receptor to the activation of phospholipase C-delta 1. Mol. Pharmacol. 2010, 77:388-395.
110. Shah B.H., Catt K.J. GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences. Trends Neurosci. 2004, 27:48-53.
111. Sabri A., Govindarajan G., Griffin T.M., Byron K.L., Samarel A.M., Lucchesi P.A. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. Circ. Res. 1998, 83:841-851.
112. Donaldson J.G., Jackson C.L. Regulators and effectors of the ARF GTPases. Curr. Opin. Cell Biol. 2000, 12:475-482.
113. Kim J.H., Kim Y., Lee S.D., Lopez I., Arnold R.S., Lambeth J.D., Suh P.G., Ryu S.H. Selective activation of phospholipase D2 by unsaturated fatty acid. FEBS Lett. 1999, 454:42-46.
114. Sarri E., Pardo R., Fensome-Green A., Cockcroft S. Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acid. Biochem. J. 2003, 369:319-329.
115. Tsukahara T., Tsukahara R., Fujiwara Y., Yue J., Cheng Y., Guo H., Bolen A., Zhang C., Balazs L., Re F., Du G., Frohman M.A., Baker D.L., Parrill A.L., Uchiyama A., Kobayashi T., Murakami-Murofushi K., Tigyi G. Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid. Mol. Cell 2010, 39:421-432.
116. Cockcroft S. Phosphatidic acid regulation of phosphatidylinositol 4-phosphate 5-kinases. Biochim. Biophys. Acta 2009, 1791:905-912.
117. van den Bout I., Divecha N. PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions. J. Cell Sci. 2009, 122:3837-3850.
118. Choi S.Y., Huang P., Jenkins G.M., Chan D.C., Schiller J., Frohman M.A. A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat. Cell Biol. 2006, 8:1255-1262.
119. Wang X., Devaiah S.P., Zhang W., Welti R. Signaling functions of phosphatidic acid. Prog. Lipid Res. 2006, 45:250-278.
120. Su W., Chen Q., Frohman M.A. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol. 2009, 5:1477-1486.
121. Brindley D.N., Pilquil C. Lipid phosphate phosphatases and signaling. J. Lipid Res. 2009, 50(Suppl):S225-S230.
122. Khalil M.B., Blais A., Figeys D., Yao Z. Lipin-the bridge between hepatic glycerolipid biosynthesis and lipoprotein metabolism. Biochim. Biophys. Acta 2010, 1801:1249-1259.
123. Merrill A.H., Wang M.D., Park M., Sullards M.C. (Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology. Trends Biochem. Sci. 2007, 32:457-468.
124. Pyne S., Lee S.C., Long J., Pyne N.J. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease. Cell. Signal. 2009, 21:14-21.
125. Rosen H., Gonzalez-Cabrera P.J., Sanna M.G., Brown S. Sphingosine 1-phosphate receptor signaling. Annu. Rev. Biochem. 2009, 78:743-768.
126. Schutze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., Kronke M. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced " acidic" sphingomyelin breakdown. Cell 1992, 71:765-776.
127. Uramura K., Funahashi H., Muroya S., Shioda S., Takigawa M., Yada T. Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area. Neuroreport 2001, 12:1885-1889.
128. Luberto C., Hannun Y.A. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?. J. Biol. Chem. 1998, 273:14550-14559.
129. Carpinteiro A., Dumitru C., Schenck M., Gulbins E. Ceramide-induced cell death in malignant cells. Cancer. Lett. 2008, 264:1-10.
130. Gomez-Munoz A. Modulation of cell signalling by ceramides. Biochim. Biophys. Acta 1998, 1391:92-109.
131. Fyrst H., Saba J.D. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat. Chem. Biol. 2010, 6:489-497.
132. Levi M., Meijler M.M., Gomez-Munoz A., Zor T. Distinct receptor-mediated activities in macrophages for natural ceramide-1-phosphate (C1P) and for phospho-ceramide analogue-1 (PCERA-1). Mol. Cell. Endocrinol. 2010, 314:248-255.
133. Hannun Y.A., Loomis C.R., Merrill A.H., Bell R.M. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 1986, 261:12604-12609.
134. Titievsky A., Titievskaya I., Pasternack M., Kaila K., Tornquist K. Sphingosine inhibits voltage-operated calcium channels in GH4C1 cells. J. Biol. Chem. 1998, 273:242-247.
135. Urs A.N., Dammer E., Sewer M.B. Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. Endocrinology 2006, 147:5249-5258.
136. Mao C., Kim S.H., Almenoff J.S., Rudner X.L., Kearney D.M., Kindman L.A. Molecular cloning and characterization of SCaMPER, a sphingolipid Ca2+ release-mediating protein from endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1993-1996.
137. Do Rego J.L., Seong J.Y., Burel D., Leprince J., Luu-The V., Tsutsui K., Tonon M.C., Pelletier G., Vaudry H. Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front. Neuroendocrinol. 2009, 30:259-301.
138. Mizukami Y. In vivo functions of GPR30/GPER-1, a membrane receptor for estrogen: from discovery to functions in vivo. Endocr. J. 2010, 57:101-107.
139. Fernandes M.S., Brosens J.J., Gellersen B. Honey, we need to talk about the membrane progestin receptors. Steroids 2008, 73:942-952.
140. Ostrom R.S, Insel P.A. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br. J. Pharmacol. 2004, 143:235-245.
141. Pani B., Singh B.B. Lipid rafts/caveolae as microdomains of calcium signaling. Cell Calcium 2009, 45:625-633.
142. Trevisani M., Smart D., Gunthorpe M.J., Tognetto M., Barbieri M., Campi B., Amadesi S., Gray J., Jerman J.C., Brough S.J., Owen D., Smith G.D., Randall A.D., Harrison S., Bianchi A., Davis J.B., Geppetti P. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat. Neurosci. 2002, 5:546-551.
143. Weil A., Moore S.E., Waite N.J., Randall A., Gunthorpe M.J. Conservation of functional and pharmacological properties in the distantly related temperature sensors TRVP1 and TRPM8. Mol. Pharmacol. 2005, 68:518-527.
144. Cho W., Stahelin R.V. Membrane binding and subcellular targeting of C2 domains. Biochim. Biophys. Acta 2006, 1761:838-849.
145. Hwang S.C., Jhon D.Y., Bae Y.S., Kim J.H., Rhee S.G. Activation of phospholipase C-gamma by the concerted action of tau proteins and arachidonic acid. J. Biol. Chem. 1996, 271:18342-18349.
146. Hardie R.C. TRP channels and lipids: from Drosophila to mammalian physiology. J. Physiol. 2007, 578:9-24.
147. D.J. Beech, Integration of TRPC channels with lipids, Acta Physiol. (Oxf.), in press. doi:10.1111/j.1748-1716.2011.02311.x.
148. Chyb S., Raghu P., Hardie R.C. Polyunsaturated fatty acids activate the Drosophila light-sensitive channels TRP and TRPL. Nature 1999, 397:255-259.
149. Venkatachalam K., Zheng F., Gill D.L. Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J. Biol. Chem. 2003, 278:29031-29040.
150. Shi J., Mori E., Mori Y., Mori M., Li J., Ito Y., Inoue R. Multiple regulation by calcium of murine homologues of transient receptor potential proteins TRPC6 and TRPC7 expressed in HEK293 cells. J. Physiol. 2004, 561:415-432.
151. Shi J., Ju M., Saleh S.N., Albert A.P., Large W.A. TRPC6 channels stimulated by angiotensin II are inhibited by TRPC1/C5 channel activity through a Ca2+- and PKC-dependent mechanism in native vascular myocytes. J. Physiol. 2010, 588:3671-3682.
152. Suh B.C., Hille B. Regulation of ion channels by phosphatidylinositol 4,5-bisphosphate. Curr. Opin. Neurobiol. 2005, 15:370-378.
153. Balla T. Regulation of Ca2+ entry by inositol lipids in mammalian cells by multiple mechanisms. Cell Calcium. 2009, 45:527-534.
154. Kwon Y., Hofmann T., Montell C. Integration of phosphoinositide- and calmodulin-mediated regulation of TRPC6. Mol. Cell 2007, 25:491-503.
155. Large W.A., Saleh S.N., Albert A.P. Role of phosphoinositol 4,5-bisphosphate and diacylglycerol in regulating native TRPC channel proteins in vascular smooth muscle. Cell Calcium 2009, 45:574-582.
156. Varnai P., Thyagarajan B., Rohacs T., Balla T. Rapidly inducible changes in phosphatidylinositol 4,5-bisphosphate levels influence multiple regulatory functions of the lipid in intact living cells. J. Cell Biol. 2006, 175:377-382.
157. Taylor C.W., Broad L.M. Pharmacological analysis of intracellular Ca2+ signalling: problems and pitfalls. Trends. Pharmacol. Sci. 1998, 19:370-375.
158. Flemming P.K., Dedman A.M., Xu S.Z., Li J., Zeng F., Naylor J., Benham C.D., Bateson A.N., Muraki K., Beech D.J. Sensing of lysophospholipids by TRPC5 calcium channel. J. Biol. Chem. 2006, 281:4977-4982.
159. Xu S.Z., Muraki K., Zeng F., Li J., Sukumar P., Shah S., Dedman A.M., Flemming P.K., McHugh D., Naylor J., Cheong A., Bateson A.N., Munsch C.M., Porter K.E., Beech D.J. A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. Circ. Res. 2006, 98:1381-1389.
160. Al-Shawaf E., Naylor J., Taylor H., Riches K., Milligan C.J., O'Regan D., Porter K.E., Li J., Beech D.J. Short-term stimulation of calcium-permeable transient receptor potential canonical 5-containing channels by oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1453-1459.
161. Hu H.Z., Xiao R., Wang C., Gao N., Colton C.K., Wood J.D., Zhu M.X. Potentiation of TRPV3 channel function by unsaturated fatty acids. J. Cell. Physiol. 2006, 208:201-212.
162. Parnas M., Peters M., Minke B. Linoleic acid inhibits TRP channels with intrinsic voltage sensitivity: implications on the mechanism of linoleic acid action. Channel. (Austin) 2009, 3:164-166.
163. Watanabe H., Vriens J., Prenen J., Droogmans G., Voets T., Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003, 424:434-438.
164. Vriens J., Owsianik G., Fisslthaler B., Suzuki M., Janssens A., Voets T., Morisseau C., Hammock B.D., Fleming I., Busse R., Nilius B. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ. Res. 2005, 97:908-915.
165. Chuang H.H., Prescott E.D., Kong H., Shields S., Jordt S.E., Basbaum A.I., Chao M.V., Julius D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001, 411:957-962.
166. Prescott E.D., Julius D. A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 2003, 300:1284-1288.
167. Liu B., Zhang C., Qin F. Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate. J. Neurosci. 2005, 25:4835-4843.
168. Lukacs V., Thyagarajan B., Varnai P., Balla A., Balla T., Rohacs T. Dual regulation of TRPV1 by phosphoinositides. J. Neurosci. 2007, 27:7070-7080.
169. Klein R.M., Ufret-Vincenty C.A., Hua L., Gordon S.E. Determinants of molecular specificity in phosphoinositide regulation. Phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P2) is the endogenous lipid regulating TRPV1. J. Biol. Chem. 2008, 283:26208-26216.
170. Kim A.Y., Tang Z., Liu Q., Patel K.N., Maag D., Geng Y., Dong X. Prit, a phosphoinositide-binding protein, functions as a regulatory subunit of TRPV1. Cell 2008, 133:475-485.
171. Mercado J, Gordon-Shaag A., Zagotta W.N., Gordon S.E. Ca2+-dependent desensitization of TRPV2 channels is mediated by hydrolysis of phosphatidylinositol 4,5-bisphosphate. J. Neurosci. 2010, 30:13338-13347.
172. Stein A.T., Ufret-Vincenty C.A., Hua L., Santana L.F., Gordon S.E. Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J. Gen. Physiol. 2006, 128:509-522.
173. Aoyagi K., Ohara-Imaizumi M., Nishiwaki C., Nakamichi Y., Nagamatsu S. Insulin/phosphatidylinositol 3-kinase pathway accelerates the glucose-induced first phase insulin secretion through TrpV2 recruitment in pancreatic beta-cells. Biochem. J. 2010, 432:375-386.
174. Monet M., Gkika D., Lehen'kyi V., Pourtier A., Vanden Abeele F., Bidaux G., Juvin V., Rassendren F., Humez S., Prevarsakaya N. Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim. Biophys. Acta 2009, 1793:528-539.
175. Lee J., Cha S.K., Sun T.J., Huang C.L. PIP2 activates TRPV5 and releases its inhibition by intracellular Mg2+. J. Gen. Physiol. 2005, 126:439-451.
176. Rohacs T., Lopes C.M., Michailidis I., Logothetis D.E. PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nat. Neurosci. 2005, 8:626-634.
177. Thyagarajan B., Lukacs V., Rohacs T. Hydrolysis of phosphatidylinositol 4,5-bisphosphate mediates calcium-induced inactivation of TRPV6 channels. J. Biol. Chem. 2008, 283:14980-14987.
178. Woo D.H., Jung S.J., Zhu M.H., Park C.K., Kim Y.H., Oh S.B., Lee C.J. Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). Mol. Pain 2008, 4:42.
179. Kim Y.H., Park C.K., Back S.K., Lee C.J., Hwang S.J., Bae Y.C., Na H.S., Kim J.S., Jung S.J., Oh S.B. Membrane-delimited coupling of TRPV1 and mGluR5 on presynaptic terminals of nociceptive neurons. J. Neurosci. 2009, 29:10000-10009.
180. Kress M., Karasek J., Ferrer-Montiel A.V., Scherbakov N., Haberberger R.V. TRPC channels and diacylglycerol dependent calcium signaling in rat sensory neurons. Histochem. Cell Biol. 2008, 130:655-667.
181. Watanabe H., Davis J.B., Smart D., Jerman J.C., Smith G.D., Hayes P., Vriens J., Cairns W., Wissenbach U., Prenen J., Flockerzi V., Droogmans G., Benham C.D., Nilius B. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. J. Biol. Chem. 2002, 277:13569-13577.
182. Chow J., Norng M., Zhang J., Chai J. TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells-mechanisms behind a possible new " hot" cancer treatment. Biochim. Biophys. Acta 2007, 1773:565-576.
183. Ciurtin C., Majeed Y., Naylor J., Sukumar P., English A.A., Emery P., Beech D.J. TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan. BMC Musculoskelet. Disord. 2010, 11:111.
184. Grimm C., Kraft R., Schultz G., Harteneck C. Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected]. Mol. Pharmacol. 2005, 67:798-805.
185. Hara Y., Wakamori M., Ishii M., Maeno E., Nishida M., Yoshida T., Yamada H., Shimizu S., Mori E., Kudoh J., Shimizu N., Kurose H., Okada Y., Imoto K., Mori Y. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol. Cell 2002, 9:163-173.
186. Oike H., Wakamori M., Mori Y., Nakanishi H., Taguchi R., Misaka T., Matsumoto I., Abe K. Arachidonic acid can function as a signaling modulator by activating the TRPM5 cation channel in taste receptor cells. Biochim. Biophys. Acta 2006, 1761:1078-1084.
187. Andersson D.A., Nash M., Bevan S. Modulation of the cold-activated channel TRPM8 by lysophospholipids and polyunsaturated fatty acids. J. Neurosci. 2007, 27:3347-3355.
188. De Petrocellis L., Starowicz K., Moriello A.S., Vivese M., Orlando P., Di Marzo V. Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids. Exp. Cell Res. 2007, 313:1911-1920.
189. Runnels L.W., Yue L., Clapham D.E. The TRPM7 channel is inactivated by PIP(2) hydrolysis. Nat. Cell Biol. 2002, 4:329-336.
190. Liu D., Liman E.R., Intracellular Ca2+ and the phospholipid PIP2 regulate the taste transduction ion channel TRPM5. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15160-15165.
191. Nilius B., Mahieu F., Prenen J., Janssens A., Owsianik G., Vennekens R., Voets T. The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate. EMBO J. 2006, 25:467-478.
192. Zhang Y., Hoon M.A., Chandrashekar J., Mueller K.L., Cook B., Wu D., Zuker C.S., Ryba N.J. Coding of sweet, bitter, and umami tastes: different receptor cells sharing similar signaling pathways. Cell 2003, 112:293-301.
193. Scott K The sweet and the bitter of mammalian taste. Curr. Opin. Neurobiol. 2004, 14:423-427.
194. Langeslag M., Clark K., Moolenaar W.H., van Leeuwen F.N., Jalink K. Activation of TRPM7 channels by phospholipase C-coupled receptor agonists. J. Biol. Chem. 2007, 282:232-239.
195. Hoffmann A., Grimm C., Kraft R., Goldbaum O., Wrede A., Nolte C., Hanisch U.K., Richter-Landsberg C., Bruck W., Kettenmann H., Harteneck C. TRPM3 is expressed in sphingosine-responsive myelinating oligodendrocytes. J. Neurochem. 2010, 114:654-665.
196. Wagner T.F., Loch S., Lambert S., Straub I., Mannebach S., Mathar I., Dufer M., Lis A., Flockerzi V., Philipp S.E., Oberwinkler J. Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells. Nat. Cell Biol. 2008, 10:1421-1430.
197. Naylor J., Li J., Milligan C.J., Zeng F., Sukumar P., Hou B., Sedo A., Yuldasheva N., Majeed Y., Beri D., Jiang S., Seymour V.A., McKeown L., Kumar B., Harteneck C., O'Regan D., Wheatcroft S.B., Kearney M.T., Jones C., Porter K.E., Beech D.J. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction. Circ. Res. 2010, 106:1507-1515.
198. Hinman A., Chuang H.H., Bautista D.M., Julius D. TRP channel activation by reversible covalent modification. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19564-19568.
199. Macpherson L.J., Dubin A.E., Evans M.J., Marr F., Schultz P.G., Cravatt B.F., Patapoutian A. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 2007, 445:541-545.
200. Chen J., Zhang X.F., Kort M.E., Huth J.R., Sun C., Miesbauer L.J., Cassar S.C., Neelands T., Scott V.E., Moreland R.B., Reilly R.M., Hajduk P.J., Kym P.R., Hutchins C.W., Faltynek C.R. Molecular determinants of species-specific activation or blockade of TRPA1 channels. J. Neurosci. 2008, 28:5063-5071.
201. Takahashi N., Mizuno Y., Kozai D., Yamamoto S., Kiyonaka S., Shibata T., Uchida K., Mori Y. Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators. Channel. (Austin) 2008, 2:287-298.
202. Salazar H., Llorente I., Jara-Oseguera A., Garcia-Villegas R., Munari M., Gordon S.E., Islas L.D., Rosenbaum T. A single N-terminal cysteine in TRPV1 determines activation by pungent compounds from onion and garlic. Nat. Neurosci. 2008, 11:255-261.
203. Chuang H.H., Lin S. Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20097-20102.
204. Riera C.E., Menozzi-Smarrito C., Affolter M., Michlig S., Munari C., Robert F., Vogel H., Simon S.A., le Coutre J. Compounds from Sichuan and Melegueta peppers activate, covalently and non-covalently, TRPA1 and TRPV1 channels. Br. J. Pharmacol. 2009, 157:1398-1409.
205. Andersson D.A., Gentry C., Moss S., Bevan S. Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J. Neurosci. 2008, 28:2485-2494.
206. Materazzi S., Nassini R., Andre E., Campi B., Amadesi S., Trevisani M., Bunnett N.W., Patacchini R., Geppetti P. Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12045-12050.
207. Taylor-Clark T.E., Undem B.J., Macglashan D.W., Ghatta S., Carr M.J., McAlexander M.A. Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1). Mol. Pharmacol. 2008, 73:274-281.
208. Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiol. Rev. 2007, 87:165-217.
209. Bai C.X., Giamarchi A., Rodat-Despoix L., Padilla F., Downs T., Tsiokas L., Delmas P. Formation of a new receptor-operated channel by heteromeric assembly of TRPP2 and TRPC1 subunits. EMBO Rep. 2008, 9:472-479.
210. Wegierski T., Steffl D., Kopp C., Tauber R., Buchholz B., Nitschke R., Kuehn E.W., Walz G., Kottgen M. TRPP2 channels regulate apoptosis through the Ca2+ concentration in the endoplasmic reticulum. EMBO J. 2009, 28:490-499.
211. Streets A.J., Needham A.J., Gill S.K., Ong A.C. Protein kinase D mediated phosphorylation of polycystin-2 (TRPP2) is essential for its effects on cell growth and calcium channel activity. Mol. Biol. Cell 2010, 21:3853-3865.
212. Ma R., Li W.P., Rundle D., Kong J., Akbarali H.I., Tsiokas L. PKD2 functions as an epidermal growth factor-activated plasma membrane channel. Mol. Cell. Biol. 2005, 25:8285-8298.
213. Bai C.X., Kim S., Li W.P., Streets A.J., Ong A.C., Tsiokas L. Activation of TRPP2 through mDia1-dependent voltage gating. EMBO J. 2008, 27:1345-1356.
214. Dong X.P., Shen D., Wang X., Dawson T., Li X., Zhang Q., Cheng X., Zhang Y., Weisman L.S., Delling M., Xu H. PI(3,5)P(2) controls membrane traffic by direct activation of mucolipin Ca release channels in the endolysosome. Nat. Commun. 2010, 1.
215. Harteneck C., Frenzel H., Kraft R. N-(p-amylcinnamoyl)anthranilic acid (ACA): a phospholipase A(2) inhibitor and TRP channel blocker. Cardiovasc. Drug. Rev. 2007, 25:61-75.
216. Chen H.C., Xie J., Zhang Z., Su L.T., Yue L., Runnels L.W. Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase. PLoS One 2010, 5:e11161.
217. Hu H., Tian J., Zhu Y., Wang C., Xiao R., Herz J.M., Wood J.D., Zhu M.X. Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs. Pflugers Arch. 2010, 459:579-592.
218. Inoue R., Okada T., Onoue H., Hara Y., Shimizu S., Naitoh S., Ito Y., Mori Y. The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)-permeable cation channel. Circ. Res. 2001, 88:325-332.
219. Hill K., Benham C.D., McNulty S., Randall A.D. Flufenamic acid is a pH-dependent antagonist of TRPM2 channels. Neuropharmacology 2004, 47:450-460.
220. Ullrich N.D., Voets T., Prenen J., Vennekens R., Talavera K., Droogmans G., Nilius B. Comparison of functional properties of the Ca2+-activated cation channels TRPM4 and TRPM5 from mice. Cell Calcium 2005, 37:267-278.
221. Niforatos W., Zhang X.F., Lake M.R., Walter K.A., Neelands T., Holzman T.F., Scott V.E., Faltynek C.R., Moreland R.B., Chen J. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597). Mol. Pharmacol. 2007, 71:1209-1216.
222. Jenkins C.M., Wolf M.J., Mancuso D.J., Gross R.W. Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2beta. Implications for structure and function. J. Biol. Chem. 2001, 276:7129-7135.
223. van Rossum D.B., Patterson R.L., Sharma S., Barrow R.K., Kornberg M., Gill D.L., Snyder S.H. Phospholipase Cgamma1 controls surface expression of TRPC3 through an intermolecular PH domain. Nature 2005, 434:99-104.
224. Kiselyov K., Kim J.Y., Zeng W., Muallem S. Protein-protein interaction and functionTRPC channels. Pflugers Arch. 2005, 451:116-124.
225. Shin Y.C., Shin S.Y., So I., Kwon D., Jeon J.H. TRIP Database: a manually curated database of protein-protein interactions for mammalian TRP channels. Nucleic Acids Res. 2011, 39:D356-D361.
226. Li R., Mouillesseaux K.P., Montoya D., Cruz D., Gharavi N., Dun M., Koroniak L., Berliner J.A. Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circ. Res. 2006, 98:642-650.
227. Choi J.W., Herr D.R., Noguchi K., Yung Y.C., Lee C.W., Mutoh T., Lin M.E., Teo S.T., Park K.E., Mosley A.N., Chun J. LPA receptors: subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol. 2010, 50:157-186.
228. Wellendorph P., Johansen L.D., Brauner-Osborne H. Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients. Mol. Pharmacol. 2009, 76:453-465.
229. Parrill A.L. Structural characteristics of lysophosphatidic acid biological targets. Biochem. Soc. Trans. 2005, 33:1366-1369.
230. Gratschev D., Lof C., Heikkila J., Bjorkbom A., Sukumaran P., Hinkkanen A., Slotte J.P., Tornquist K. Sphingosine kinase as a regulator of calcium entry through autocrine sphingosine 1-phosphate signaling in thyroid FRTL-5 cells. Endocrinology 2009, 150:5125-5134.
231. K. Törnquist, Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells, Acta Physiol. (Oxf.), in press. doi:10.1111/j.1748-1716.2011.02265.x.
232. Chan B.S., Satriano J.A., Pucci M., Schuster V.L. Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter " PGT" J. Biol. Chem. 1998, 273:6689-6697.
233. Schuster V.L. Prostaglandin transport. Prostaglandins Other Lipid Mediat. 2002, 68-69:633-647.
234. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., Stevens R.C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318:1258-1265.
235. Garcia-Sainz J.A., Vazquez-Prado J., del Carmen Medina L. Alpha 1-adrenoceptors: function and phosphorylation. Eur. J. Pharmacol. 2000, 389:1-12.
236. Mao L.M., Liu X.Y., Zhang G.C., Chu X.P., Fibuch E.E., Wang L.S., Liu Z., Wang J.Q. Phosphorylation of group I metabotropic glutamate receptors (mGluR1/5) in vitro and in vivo. Neuropharmacology 2008, 55:403-408.